Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
JAZZ compared with LZB: revenue, margins and what each company keeps, and the suppliers and customers both name
JAZZ
Jazz Pharmaceuticals plc
Change
Mkt cap
Revenue
Revenue
LZB
La-Z-Boy Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
JAZZ
Jazz Pharmaceuticals plc
vs
LZB
La-Z-Boy Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
JAZZ
0 of 1
at or beyond implied
Report
implied
realized
× implied
Aug 4 '26
±6.8%
▲
+3.99%
×0.59
May 6 '26
—
▲
+7.68%
—
Feb 25 '26
—
▲
+13.23%
—
Jan 12 '26
—
▲
+1.58%
—
LZB
3 of 4
at or beyond implied
Report
implied
realized
× implied
Aug 19 '26
±8.7%
▼
−16.95%
×1.94
Jun 17 '26
±9.6%
▲
+14.77%
×1.54
= implied
JAZZ realized, solid
LZB realized, hatched
One scale, both sides: full bar = 21%
× = |realized| ÷ implied
Source: market data
Feb 18 '26
±10.2%
▼
−6.33%
×0.62
Nov 19 '25
±7.2%
▲
+20.21%
×2.81
JAZZ
Jazz Pharmaceuticals plc
Change
216.26
▲
+0.13%
· post 214.43
Mkt cap
$14.0B
Revenue
$1.2B
Q3 FY26
Revenue
$4.3B
FY25
LZB
La-Z-Boy Inc
Change
31.73
▲
+4.24%
· post 31.73
Closed
Nov 2 '26
Mkt cap
$1.2B
Revenue
$476M
Q1 FY27
Revenue
$2.1B
FY26
vs
Compare
Closed
Nov 2 '26
JAZZ
Jazz Pharmaceuticals plc
vs
LZB
La-Z-Boy Inc
216.26
▲
+0.13%
post 214.43
Price
31.73
▲
+4.24%
post 31.73
$14.0B
Mkt cap
$1.2B
Q3 FY26
$1.2B
Revenue
$476M
Q1 FY27
FY25
$4.3B
Revenue
$2.1B
FY26
Change
Change
JAZZ
216.26
▲
+0.13%
vs
LZB
31.73
▲
+4.24%
Closed
Nov 2 '26